Edge Rewrite
// HTMLRewriter · presentation

This page was redesigned at the edge.

Cloudflare fetched the original article and streamed it through HTMLRewriter to apply an entirely new visual system without rebuilding the source page.

// request.cf · coarse context

A page that knows where it met you.

Only coarse request metadata is shown. This demo does not display or persist visitor IP addresses.

Country
US
Cloudflare location
CMH
Connection
HTTP/2
Language
Not provided

Ray ID: a24e92fe68d8bdc9

Jump to content

Talk:TroVax

Page contents not supported in other languages.
Add topic
From Wikipedia, the free encyclopedia
Latest comment: 12 years ago by 108.70.148.42 in topic Opening Paragraph

This

[edit]

This page appears to be quite spammy. Also, the article is about a UK company but uses US "tumor" not UK "tumour", but I've left those.

The end line about "rumoured to be interested" should probably be deleted too. DanBeale 13:49, 3 March 2007 (UTC)Reply

The rumoured to be interested should be changed to the fact that sanofi-aventis entered a global development and commercialisation agreement for TroVax in March 2007 Clark 14:31, 3 October 2007 (UTC)

I've now done that, but this page still needs work WRT referencing and links.Clark 14:46, 3 October 2007 (UTC)Reply

Opening Paragraph

[edit]

The opening paragraph is inaccessible to anyone (me included) who doesn't have a background in medicine. "delivers a novel proprietary tumor-associated antigen, 5T4, using a pox virus vector", for example. Thedreamdied 19:46, 29 March 2007 (UTC)Reply

It also includes an untrue statement, referenced to 2006, that no cancer vaccines have been proven to prolong human life. There is one that has been proven to do so and it is commercially available (for prostate cancer). Chuck — Preceding unsigned comment added by 108.70.148.42 (talk) 20:19, 24 January 2014 (UTC)Reply